It began as a supposed revolution in sport—an enterprise not merely challenging the establishment but seeking to dismantle it altogether. Enhanced is built on a radical premise: that athletic competition should embrace medical science rather than prohibit it. When Aron D’Souza unveiled the Enhanced Games in 2023, the concept was deliberately provocative. Athletes would be allowed—indeed encouraged—to use performance-enhancing substances under medical supervision, with world records rewarded by prizes of up to $1 million.
What set Enhanced apart, at least rhetorically, was its financial model. Unlike the Olympics, it promised direct payment to athletes: appearance fees, prize money, and substantial rewards for record-breaking performances. Backed by a range of investors (in contrast to Michael Johnson’s ill-fated Grand Slam Track project, which collapsed under shaky financial assumptions), Enhanced also positioned itself as more than a sporting event. It aims to develop a consumer-facing line of products focused on health, longevity, and recovery—an attempt to anchor the project in a broader commercial ecosystem.
On paper, the vision has a certain appeal. Athletics without the IOC, without bans framed as “outdated,” without the moralising rhetoric around “natural” performance. Enhanced claims to prioritise transparency and medical oversight, reframing enhancement not as cheating but as controlled optimisation. The Games were intended not just as a competition, but as proof of concept: that sport could be reimagined as both scientifically honest and commercially viable. The implicit question was simple: what would human performance look like without imposed limits?
The answer, at least for now, is underwhelming.
The first Enhanced Games, held on May 24 in Las Vegas, fell far short of their grand claims. Instead of a cascade of world records, organisers produced a single headline result: Kristian Gkolomeev’s 20.81 in the 50m freestyle. Even that performance raised eyebrows. There were claims that the time appeared on the screen before the swimmer touched the wall, and in any case Gkolomeev wore a full-body suit—equipment banned in official competition. With those caveats, the legitimacy of the “record” is, at best, debatable.
As for the athletes who did follow enhancement protocols, the organisers provided only aggregate data. They reported that 91% used testosterone, 79% human growth hormone, and 29% anabolic steroids over a nine-week period, alongside other substances such as stimulants and erythropoietin. Some older competitors reportedly outperformed their younger selves, with 21 personal bests recorded across 13 athletes. Yet these gains failed to translate into performances that challenged the global elite.
This leaves a striking disconnect. On one side, the promotional rhetoric of Enhanced.com promises
“the future of sport—where science, athleticism, and progress inspire superhuman achievement”.
On the other, critics, such as Travis Tygart (head of USADA, who tried to cover the E. Knighton scandal), have been far more direct:
“While those behind the Enhanced Games might be looking to make a quick buck, that profit would come at the expense of kids across the world thinking they need to dope to chase their dreams. We desperately wish this investment was being made in the athletes who are currently training and competing the real and safe way. They are the role models this world so desperately needs and they are the ones who deserve our support—not some dangerous clown show that puts profit over principle”.
If anything, the inaugural Enhanced Games delivered a simpler lesson than either side anticipated. Pharmaceutical assistance did not redefine the limits of performance, nor did it overturn the existing hierarchy. And perhaps most tellingly, two of the event’s winners proved that even in a competition built around enhancement, it was still possible to prevail without it.